Evaluation of serum mid-infrared spectroscopy as new prognostic marker for bevacizumab-based chemotherapy in first-line treatment of metastatic colorectal cancer

Affiliation auteurs!!!! Error affiliation !!!!
TitreEvaluation of serum mid-infrared spectroscopy as new prognostic marker for bevacizumab-based chemotherapy in first-line treatment of metastatic colorectal cancer
Type de publicationJournal Article
Year of Publication2021
AuteursChautard R., Leger J., Bouche O., Borg C., Douillard J-Y., Manfredi S., Terrebonne E., Capitain O., Spano J-P., Caulet M., Raoul W., Gueguinou M., Herault O., Ferru A., Pobel C.J, Sire O., Lecomte T.
JournalANNALS OF ONCOLOGY
Volume32
PaginationS571
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2021.08.1002